AEROSOL FORMULATION FOR COPD
First Claim
Patent Images
1. A pharmaceutical composition, comprising glycopyrronium chloride dissolved in an HFA propellant and optionally a co-solvent, wherein said composition comprises an amount of acid equivalent to 0.05 to 0.4 mg/μ
- l of 1M HCl.
1 Assignment
0 Petitions
Accused Products
Abstract
The stable aerosol solution formulations comprising glycopyrronium chloride are useful for administration to patients with COPD and other respiratory conditions.
-
Citations
17 Claims
- 1. A pharmaceutical composition, comprising glycopyrronium chloride dissolved in an HFA propellant and optionally a co-solvent, wherein said composition comprises an amount of acid equivalent to 0.05 to 0.4 mg/μ
Specification